166 related articles for article (PubMed ID: 8391806)
1. The cyclic-AMP antagonist adenosine-3',5'-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitro.
Ljunggren O; Ljunghall S
Biochem Biophys Res Commun; 1993 Jun; 193(3):821-6. PubMed ID: 8391806
[TBL] [Abstract][Full Text] [Related]
2. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
[TBL] [Abstract][Full Text] [Related]
3. Use of the cyclic AMP antagonist, Rp-cAMPS, to distinguish between cyclic AMP-dependent and cyclic AMP-independent contractile responses in rat ventricular cardiomyocytes.
Bell D; McDermott BJ
J Mol Cell Cardiol; 1994 Nov; 26(11):1439-48. PubMed ID: 7897668
[TBL] [Abstract][Full Text] [Related]
4. Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy.
Lerner UH; Grubb A
J Bone Miner Res; 1992 Apr; 7(4):433-40. PubMed ID: 1319105
[TBL] [Abstract][Full Text] [Related]
5. The activation of cAMP-dependent protein kinase is directly linked to the stimulation of bone resorption by parathyroid hormone.
Kaji H; Sugimoto T; Kanatani M; Fukase M
Biochem Biophys Res Commun; 1992 Feb; 182(3):1356-61. PubMed ID: 1311571
[TBL] [Abstract][Full Text] [Related]
6. Role of dual signal transduction systems in the stimulation of bone resorption by parathyroid hormone-related peptide. The direct involvement of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Fukase M; Chihara K
Horm Metab Res; 1993 Aug; 25(8):421-4. PubMed ID: 8225186
[TBL] [Abstract][Full Text] [Related]
7. Cholera toxin-stimulated bone resorption in cultured mouse calvarial bones not inhibited by calcitonin: a possible interaction at the stimulatory G protein.
Ransjö M; Lerner UH; Ljunggren O
J Bone Miner Res; 1994 Dec; 9(12):1927-34. PubMed ID: 7872058
[TBL] [Abstract][Full Text] [Related]
8. PTH and PTH-rP elicit dissimilar retractile responses in murine MC3T3-E1 osteoblasts.
Murray EJ; Murray SS; Tram KK; Lee DB
Exp Cell Res; 1994 Dec; 215(2):241-8. PubMed ID: 7982466
[TBL] [Abstract][Full Text] [Related]
9. Forskolin mimics the effects of calcitonin but not parathyroid hormone on bone resorption in vitro.
Klein RF; Nissenson RA; Strewler GJ
Bone Miner; 1988 Jul; 4(3):247-56. PubMed ID: 2847839
[TBL] [Abstract][Full Text] [Related]
10. Characterization of adenosine receptors in bone. Studies on the effect of adenosine analogues on cyclic AMP formation and bone resorption in cultured mouse calvaria.
Lerner UH; Sahlberg K; Fredholm BB
Acta Physiol Scand; 1987 Oct; 131(2):287-96. PubMed ID: 2823534
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclic AMP-dependent protein kinase-induced changes in the kinetic properties of hepatic pyruvate kinase by the specific cyclic AMP antagonist, the (Rp)-diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Dragland-Meserve CJ; Rothermel JD; Houlihan MJ; Botelho LH
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):371-82. PubMed ID: 2993387
[TBL] [Abstract][Full Text] [Related]
12. Forskolin sensitizes parathyroid hormone-induced cyclic AMP response, but not the bone resorptive effect, in mouse calvarial bones.
Lerner UH; Ransjö M; Sahlberg K; Ljunggren O; Fredholm BB
Bone Miner; 1989 Jan; 5(2):169-81. PubMed ID: 2537671
[TBL] [Abstract][Full Text] [Related]
13. Isoproterenol inhibits rod outer segment phagocytosis by both cAMP-dependent and independent pathways.
Kuriyama S; Hall MO; Abrams TA; Mittag TW
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):730-6. PubMed ID: 7890503
[TBL] [Abstract][Full Text] [Related]
14. Bone resorption induced by A23187 is abolished by indomethacin: implications for second messenger utilised by parathyroid hormone.
Bornefalk E; Ljunghall S; Ljunggren O
Eur J Pharmacol; 1998 Mar; 345(3):333-8. PubMed ID: 9592034
[TBL] [Abstract][Full Text] [Related]
15. A revised role for cyclic AMP in prostaglandin-induced bone resorption.
Lerner U; Gustafson GT
Med Biol; 1980 Feb; 58(1):18-24. PubMed ID: 6247586
[TBL] [Abstract][Full Text] [Related]
16. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.
Lerner UH; Fredholm BB; Ransjö M
Biochem J; 1986 Dec; 240(2):529-39. PubMed ID: 3028378
[TBL] [Abstract][Full Text] [Related]
17. Forskolin has both stimulatory and inhibitory effects on bone resorption in fetal rat long bone cultures.
Lorenzo JA; Sousa S; Quinton J
J Bone Miner Res; 1986 Aug; 1(4):313-7. PubMed ID: 2459910
[TBL] [Abstract][Full Text] [Related]
18. Effects of cholera toxin on cyclic AMP accumulation and bone resorption in cultured mouse calvaria.
Ransjö M; Lerner UH
Biochim Biophys Acta; 1987 Oct; 930(3):378-91. PubMed ID: 2820504
[TBL] [Abstract][Full Text] [Related]
19. Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway.
Kaji H; Sugimoto T; Kanatani M; Nasu M; Chihara K
Endocrinology; 1996 Jun; 137(6):2217-24. PubMed ID: 8641168
[TBL] [Abstract][Full Text] [Related]
20. Bone resorption induced by parathyroid hormone and dibutyryl cyclic AMP: role of carbonic anhydrase.
Hall GE; Kenny AD
J Pharmacol Exp Ther; 1986 Sep; 238(3):778-82. PubMed ID: 3018220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
